Phase I/II Study Evaluating AUTO4 in Patients With T Cell Receptor Beta Constant (TRBC)1 Positive T Cell Lymphoma
Autolus Limited
Autolus Limited
Roswell Park Cancer Institute
Wake Forest University Health Sciences
Fondazione Italiana Linfomi - ETS
Pfizer
Emergent BioSolutions
Rutgers, The State University of New Jersey
Dana-Farber Cancer Institute
miRagen Therapeutics, Inc.
Brown University
Spectrum Pharmaceuticals, Inc
Weprom
Fred Hutchinson Cancer Center
Celgene
Fred Hutchinson Cancer Center
National Institutes of Health Clinical Center (CC)
University of Rochester
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center